A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 21,509 shares of EWTX stock, worth $637,096. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,509
Previous 49,597 56.63%
Holding current value
$637,096
Previous $893,000 35.72%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.88 - $29.5 $446,037 - $828,596
-28,088 Reduced 56.63%
21,509 $574,000
Q2 2024

Aug 14, 2024

BUY
$15.08 - $21.23 $747,922 - $1.05 Million
49,597 New
49,597 $893,000
Q2 2021

Aug 16, 2021

SELL
$21.33 - $30.25 $6.4 Million - $9.08 Million
-300,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$30.0 - $35.99 $9 Million - $10.8 Million
300,000 New
300,000 $9.75 Million

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.87B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.